April 30, 2017 10:15 AM ET

Biotechnology

Company Overview of PharmAkea, Inc.

Company Overview

PharmAkea, Inc. operates as a biopharmaceutical company in California. The company discovers and develops small molecule therapeutics for cancer and fibrotic diseases. Its lead program includes a small molecule LOXL2 inhibitor. PharmAkea Inc. has a strategic collaboration with Celgene Corporation to leverage PharmAkea's proprietary drug discovery platform and novel small molecule therapies targeting fibrotic diseases. The company was founded in 2012 and is based in San Diego, California.

3030 Bunker Hill

Suite 300

San Diego, CA 92109

United States

Founded in 2012

Phone:

650-493-9300

Key Executives for PharmAkea, Inc.

Chief Executive Officer and Director
Age: 50
Co-Founder and President
Founder and Member of Scientific Advisory Board
Founder and Chief Operating Officer
Vice President of Finance
Compensation as of Fiscal Year 2016.

PharmAkea, Inc. Key Developments

PharmAkea Inc. Extends Collaboration with Celgene Corporation

PharmAkea Inc. announced the extension of their strategic collaboration with Celgene Corporation which was established to leverage PharmAkea's proprietary drug discovery platform and novel small-molecule therapies targeting fibrotic diseases. Under the terms of the agreement, Celgene Corporation committed $9 million to PharmAkea to extend the collaboration for 9 months. PharmAkea announced the original 3-year collaboration with Celgene in October of 2013. PharmAkea is currently conducting a Phase 1 SAD and MAD trial, as well as toxicology studies that will enable Phase 2 trials on its lead program, a small molecule LOXL2 inhibitor. The company is also conducting IND-enabling studies in preparation for a Phase 1 trial on its second program.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
November 18, 2016
--
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact PharmAkea, Inc., please visit www.pharmakea.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.